biote Corp (BTMD)

NASDAQ
Currency in USD
3.87
-0.11(-2.76%)
Closed·
After Hours
3.870.00(0.00%)
·
BTMD Scorecard
Full Analysis
Net income is expected to grow this year
BTMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.824.06
52 wk Range
3.048.44
Key Statistics
Edit
Prev. Close
3.87
Open
3.98
Day's Range
3.82-4.06
52 wk Range
3.04-8.44
Volume
86.1K
Average Volume (3m)
216.64K
1-Year Change
-30.52%
Book Value / Share
-2.86
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BTMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.67
Upside
+72.22%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

biote Corp Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

biote Corp Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $0.37 beat $0.14 forecast; revenue of $49M exceeded $47.2M estimate; stock rose 10.78% after hours
  • Revenue up 4.7% YoY, driven by 25.5% growth in dietary supplements; gross profit margin improved 300bps to 74.3%
  • 2025 guidance: $202-208M revenue, $59-64M adjusted EBITDA; Q2 restructuring charge of $600-800K expected
  • CEO highlighted growth potential; CFO emphasized strategic initiatives to drive new penetrations
  • Risks include decreased procedure revenue, restructuring costs, and competitive pressures; company maintains strong financials
Last Updated: 2025/05/07, 23:48
Read Full Transcript

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.67
(+72.22% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.37 / 0.14
Revenue / Forecast
49.00M / 47.20M
EPS Revisions
Last 90 days

FAQ

What Is the biote Corp (BTMD) Stock Price Today?

The biote Corp stock price today is 3.87

What Stock Exchange Does biote Corp Trade On?

biote Corp is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for biote Corp?

The stock symbol for biote Corp is "BTMD."

What Is the biote Corp Market Cap?

As of today, biote Corp market cap is 189.73M.

What Is biote Corp's Earnings Per Share (TTM)?

The biote Corp EPS (TTM) is 0.63.

When Is the Next biote Corp Earnings Date?

biote Corp will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is BTMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has biote Corp Stock Split?

biote Corp has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.